Premium
Mirum Pharmaceuticals Inc (MIRM)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC... Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -5.28 | -10.2984201287 | 51.27 | 51.75 | 32.01 | 633272 | 48.00110394 | CS |
| 4 | -2.37 | -4.90074441687 | 48.36 | 54.234 | 32.01 | 564957 | 50.52090991 | CS |
| 12 | 2.85 | 6.60639777469 | 43.14 | 54.234 | 32.01 | 507422 | 46.83912392 | CS |
| 26 | 4.78 | 11.5991264256 | 41.21 | 54.234 | 32.01 | 428013 | 44.14620435 | CS |
| 52 | 16.34 | 55.1096121417 | 29.65 | 54.234 | 23.14 | 520170 | 36.83503235 | CS |
| 156 | 25.57 | 125.220372184 | 20.42 | 54.234 | 17.315 | 462830 | 29.97480548 | CS |
| 260 | 28.85 | 168.319719953 | 17.14 | 54.234 | 9.14 | 326766 | 28.12810256 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
